Marker Therapeutics Inc (MRKR)

[Bio7mm]

Dilution may not occur at all after the reverse split! On May 24, 2010, Tapimmune sold $1.5 million in Secured Convertible Notes. They were issued with warrants to buy common shares but I don't think they created dilution the day they received the $1.5 million from investors. If they play it right, they do the reverse split, issue some great news to get the price up over $5 and then secure only the funding needed through a debt offering to complete some trials. Maybe the future exercise price is over $5! Remember, when the reverse split takes place Wilson and the senior leadership team get their preferred shares converted to common shares. Wouldn't you do that if you thought the price of the common shares had a really good chance of rising?